44net

44net@mailman.ampr.org

2 participants
3205 discussions

Re: 44net Digest, Vol 42, Issue 3
by David Witten 01 Nov '26

01 Nov '26

If I continue to get this crap I am going to discontinue all my use of AMPR and 44Net. Dave, KD0EAG On Fri, 30 Oct 2026 at 07:00, <44net-request(a)mailman.ampr.org> wrote: > Send 44net mailing list submissions to > 44net(a)mailman.ampr.org > > To subscribe or unsubscribe via email, send a message with subject or > body 'help' to > 44net-request(a)mailman.ampr.org > > You can reach the person managing the list at > 44net-owner(a)mailman.ampr.org > > When replying, please edit your Subject line so it is more specific > than "Re: Contents of 44net digest..."Today's Topics: > > 1. Amino Acids Premix for Feed Market Trends Driving Smarter Animal > Nutrition > (riyaj.reed(a)gmail.com) > > > > ---------- Forwarded message ---------- > From: riyaj.reed(a)gmail.com > To: 44net(a)mailman.ampr.org > Cc: > Bcc: > Date: Fri, 30 Oct 2026 10:00:36 -0000 > Subject: [44net] Amino Acids Premix for Feed Market Trends Driving Smarter > Animal Nutrition > The amino acids premix for feed market is growing as livestock producers > look for precise, cost-effective ways to improve animal health and > productivity. Premixes combine amino acids with vitamins, minerals, and > carriers into a ready-to-blend format, so feed mills can deliver consistent > nutrition to poultry, swine, cattle, and aquaculture species. > > Demand for essential amino acids such as lysine, methionine, threonine, > and tryptophan is a major trend behind this growth. Animals cannot make > these nutrients on their own, so balanced supplementation supports growth, > immunity, and efficient protein use while reducing dependence on expensive > protein meals. > > Precision nutrition is reshaping formulation practices. Producers now > tailor diets to species, age, and production stage, and premix suppliers > offer customized blends that match these requirements. Digital tools and > feed analysis software help nutritionists fine-tune ratios and cut waste. > > Sustainability is another important trend. Lower crude protein diets > supplemented with amino acids reduce nitrogen excretion, which limits > ammonia emissions and water pollution. Regulators and large meat buyers > increasingly favor suppliers that can show a smaller environmental > footprint. > > Rising meat consumption keeps the market moving. Population growth, > urbanization, and higher incomes in Asia-Pacific, Latin America, and Africa > are lifting demand for poultry, pork, and fish. This puts pressure on > producers to raise output efficiently, and premixes help achieve better > feed conversion. > > Innovation in production is also notable. Fermentation-based > manufacturing, improved encapsulation, and rumen-protected formats are > expanding the range of applications, especially for dairy cattle where > amino acids must survive digestion to be useful. > > Regionally, Asia-Pacific leads in volume thanks to its large livestock > sector, while Europe and North America focus on quality, traceability, and > sustainability. Brazil and Southeast Asia are emerging as fast-growing > centers. > > Challenges include raw material price volatility and the need for strict > quality control. Even so, the long-term outlook is positive. Suppliers that > offer reliable, science-backed, and environmentally responsible premixes > will be best placed to capture growth as global protein demand continues to > climb. > > Read More: > https://www.marketresearchfuture.com/reports/amino-acids-premix-for-feed-ma… > _______________________________________________ > 44net mailing list -- 44net(a)mailman.ampr.org > To unsubscribe send an email to 44net-leave(a)mailman.ampr.org >

10 10

Amino Acids Premix for Feed Market Trends Driving Smarter Animal Nutrition
by riyaj.reed＠gmail.com 30 Oct '26

30 Oct '26

The amino acids premix for feed market is growing as livestock producers look for precise, cost-effective ways to improve animal health and productivity. Premixes combine amino acids with vitamins, minerals, and carriers into a ready-to-blend format, so feed mills can deliver consistent nutrition to poultry, swine, cattle, and aquaculture species. Demand for essential amino acids such as lysine, methionine, threonine, and tryptophan is a major trend behind this growth. Animals cannot make these nutrients on their own, so balanced supplementation supports growth, immunity, and efficient protein use while reducing dependence on expensive protein meals. Precision nutrition is reshaping formulation practices. Producers now tailor diets to species, age, and production stage, and premix suppliers offer customized blends that match these requirements. Digital tools and feed analysis software help nutritionists fine-tune ratios and cut waste. Sustainability is another important trend. Lower crude protein diets supplemented with amino acids reduce nitrogen excretion, which limits ammonia emissions and water pollution. Regulators and large meat buyers increasingly favor suppliers that can show a smaller environmental footprint. Rising meat consumption keeps the market moving. Population growth, urbanization, and higher incomes in Asia-Pacific, Latin America, and Africa are lifting demand for poultry, pork, and fish. This puts pressure on producers to raise output efficiently, and premixes help achieve better feed conversion. Innovation in production is also notable. Fermentation-based manufacturing, improved encapsulation, and rumen-protected formats are expanding the range of applications, especially for dairy cattle where amino acids must survive digestion to be useful. Regionally, Asia-Pacific leads in volume thanks to its large livestock sector, while Europe and North America focus on quality, traceability, and sustainability. Brazil and Southeast Asia are emerging as fast-growing centers. Challenges include raw material price volatility and the need for strict quality control. Even so, the long-term outlook is positive. Suppliers that offer reliable, science-backed, and environmentally responsible premixes will be best placed to capture growth as global protein demand continues to climb. Read More: https://www.marketresearchfuture.com/reports/amino-acids-premix-for-feed-ma…

1 0

Off Topic - Linfbb
by Peter Mallett 28 Oct '26

28 Oct '26

Hi All, Just an update on the issue I found here. Checking the logs revealed a Date / Time error which is a bit strange but this is what happened. Just to be tidy, in fbb.conf, I added a "hyphen" to the version like this, version = FBB-7.0.14 the original did not have a "hyphen " and was like this, version = FBB7.0.11 as for the previous version I was running. Now this "hyphen" caused my housekeep files to report an incorrect Date / Time so I removed the "hyphen", verson = FBB7.0.14 and all was good. So NO errors in Linfbb but instead just me being tidy, Hi Hi. Great work Bernard. Regards ..... Peter ZL2BAU

1 0

Very Off Topic
by Peter Mallett 28 Oct '26

28 Oct '26

Hi All, Sorry for this message which is way off topic. I have upgraded my Linfbb from version 7.0.11 to version 7.0.14 and it no longer does housekeep. As there is very little info on linfbb these days, I wonder if anyone here has done the same and has an issue or can point me in the right direction to find someone who is dealing with xfbb these days ? Many thanks and apologies for the very off topic. Regards ..... Peter ZL2BAU

1 0

Cellular Senescence Interventions and Senolytic Therapeutics Driving Longevity Market Growth
by anujmrfr1＠gmail.com 14 Oct '26

14 Oct '26

Targeting biological aging pathways to extend healthspan and prevent age-related multi-organ degeneration is establishing longevity biotechnology as a transformative healthcare sector. Detailed analysis within the Longevity Market report demonstrates how senolytic small molecules, cellular reprogramming vectors, and NAD+ restoration therapies target the hallmarks of aging. Clearing dysfunctional senescent cells and restoring mitochondrial bioenergetics address underlying drivers of cardiovascular disease, neurodegeneration, and metabolic decline.Additionally, high-profile venture capital investments and specialized longevity research institutes are accelerating early-stage pipeline development. read more @https://www.marketresearchfuture.com/reports/longevity-market-42067 Capital inflows support clinical trials for geroprotective therapeutics.Furthermore, regulatory frameworks are evolving toward recognizing aging biomarkers and frailty measures as valid clinical trial endpoints. Establishing biological age metrics streamlines regulatory approval pathways for novel anti-aging therapeutics.As global demographics shift toward older populations, science-backed longevity interventions remain vital to sustainable preventive healthcare.Do you think senolytic drug combinations will receive formal regulatory approval for age-reversal indications within this decade?People Also AskHow do senolytic therapies selectively eliminate senescent "zombie" cells in aging tissue?Senolytics temporarily disable pro-survival pathways in senescent cells, triggering apoptosis without harming surrounding healthy tissue.What primary role do NAD+ boosting compounds play in cellular healthspan extension?NAD+ precursors restore intracellular coenzyme levels required for mitochondrial ATP production and DNA-repair sirtuin enzyme activation.#Longevity #BiotechResearch #HealthyAging #Senolytics #PreventiveMedicine

1 0

Artificial Intelligence (AI) in Healthcare Market: Industry Trends and Global Forecasts, till 2035
by nidhithankur987＠gmail.com 09 Oct '26

09 Oct '26

Market Size and Growth ProjectionsCurrent Value (2025): Estimated at $35.71 billion Long-Term Forecast (2035): Projected to reach $765.12 billion by 2035 Growth Rate: Anticipated to expand at a robust compound annual growth rate (CAGR) of 35.9%. Sub-Segment Highlights (Generative AI & Clinical Trials)Generative AI in Healthcare: Valued at $3.3 billion in 2025, growing to $4.7 billion in 2026, and forecasted to hit $39.8 billion by 2035 (CAGR of 26.7%). AI in Clinical Trials: Projected to reach $11.61 billion by 2035, growing at a CAGR of 12.7% to address high drug development costs, patient recruitment bottlenecks, and trial inefficiencies. Key Application Areas & Drivers Core Applications: Spans drug discovery and development, diagnostic imaging, personalized treatment plans, and administrative automation (such as EHR documentation and conversational clinical notes). End-Users: Pharmaceutical and life sciences companies represent a rapidly expanding segment due to heavy usage in research-intensive workflows. Geographic Adoption: North America commands the largest market share (over 55% in specialized sub-segments like Generative AI), while Asia-Pacific emerges as the fastest-growing region fueled by health-IT modernization. Conclusion The integration of artificial intelligence into healthcare is rapidly evolving from an experimental tool into a core operational and clinical necessity. Propelled by an exceptional 35.9% CAGR and a trajectory toward a $765 billion valuation by 2035, AI is fundamentally redefining pharmaceutical research, diagnostic precision, and administrative workflows. As specialized sub-segments like generative AI and clinical trial optimization scale globally—led by strong adoption in North America and surging IT modernization across Asia-Pacific—artificial intelligence will permanently reshape the speed, accuracy, and efficiency of modern medicine. https://www.rootsanalysis.com/artificial-intelligence-market

1 0

Fermenters and Bioreactors Market
by nidhithankur987＠gmail.com 09 Oct '26

09 Oct '26

The integration of artificial intelligence into healthcare is rapidly evolving from an experimental tool into a core operational and clinical necessity. Propelled by an exceptional 35.9% CAGR and a trajectory toward a $765 billion valuation by 2035, AI is fundamentally redefining pharmaceutical research, diagnostic precision, and administrative workflows. As specialized sub-segments like generative AI and clinical trial optimization scale globally—led by strong adoption in North America and surging IT modernization across Asia-Pacific—artificial intelligence will permanently reshape the speed, accuracy, and efficiency of modern medicine

1 0

WAN IP change problem
by Libor Berka 13 Aug '26

13 Aug '26

My WAN IP 179.223.1.162 changed to 100.71.129.62 after installing new router. It corresponds to host "medvidek.ddnsfree.com" and it was reconfigured in amprnet portal. But that old IP not changed to new one in 44 network: 44.63.16.112/28 via 179.223.1.162 dev tunl0 proto 44 onlink window 840 Why it not changed to: 44.63.16.112/28 via 100.71.129.62 dev tunl0 proto 44 onlink window 840 Please help. Tks/73 Libor

2 1

Re: WAN IP change problem
by Lee D Bengston 13 Aug '26

13 Aug '26

Resending to the group, which was the original intent. On Thu, Aug 13, 2026 at 10:16 AM Lee D Bengston <kilo5dat(a)gmail.com> wrote: > My XRouter node receives the RIP broadcasts, and it has the updated route. > > ip route lookup 44.63.16.112 > > > K5DAT-5:DATXR} Route to 44.63.16.112/28 is via 100.71.129.62, mode e > > 73, > Lee K5DAT > >

2 1

ZL2BAU BBS and Links
by Peter Mallett 19 Jun '26

19 Jun '26

Hi All, Just a reminder that the IP here has changed a while back and is now 115.187.97.232 altho I would prefer if everyone uses zl2bau.co.nz as the IP will change again at some stage as I no longer run with a static IP. Please let me know if there are any changes by anyone as I have a few that do not appear to be about at the moment. Regards ..... Peter ZL2BAU

1 0

Jump to page:

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

44net